It was further shown that the pre-existing type 2 immune signature upon the commencement of CS exposure likely contributed to the onset of emphysema with increased production of MMP-12 and recruited pathogenic lung macrophage populations such as interstitial macrophages. The gene discussed is MMP12; the disease is pulmonary emphysema.